114 related articles for article (PubMed ID: 3749811)
1. Symptomatic recurrence of healed duodenal and prepyloric ulcers after treatment with ranitidine or high-dose antacid. A 1-year follow-up study.
Bytzer P; Lauritsen K; Rask-Madsen J
Scand J Gastroenterol; 1986 Aug; 21(6):765-8. PubMed ID: 3749811
[TBL] [Abstract][Full Text] [Related]
2. Comparison of ranitidine and high-dose antacid in the treatment of prepyloric or duodenal ulcer. A double-blind controlled trial.
Lauritsen K; Bytzer P; Hansen J; Bekker C; Rask-Madsen J
Scand J Gastroenterol; 1985 Jan; 20(1):123-8. PubMed ID: 3887547
[TBL] [Abstract][Full Text] [Related]
3. Maintenance therapy for duodenal ulcer: a randomized controlled comparison of seven forms of treatment.
Hui WM; Lam SK; Lok AS; Ng MM; Lai CL
Am J Med; 1992 Mar; 92(3):265-74. PubMed ID: 1546725
[TBL] [Abstract][Full Text] [Related]
4. Ranitidine in the treatment of gastric, prepyloric and duodenal ulcer--a controlled prospective double-blind trial.
Darle N; Almskog B; Falk A; Fredriksen B; Gamklou R; Ivarsson L; Karlström L
Ann Clin Res; 1984; 16(1):6-9. PubMed ID: 6331270
[TBL] [Abstract][Full Text] [Related]
5. Are endoscopic and/or histologic findings in gastroduodenal mucosa a predictor of clinical outcome in peptic ulcer disease? A 1-year follow-up study after initial healing with either cimetidine or medium-dose antacid.
Jönsson KA; Bodemar G; Norrby K; Walan A; Tysk C
Scand J Gastroenterol; 1988 Mar; 23(2):199-208. PubMed ID: 3283917
[TBL] [Abstract][Full Text] [Related]
6. A comparison of 4-week peptic ulcer healing rates following treatment with antacids and ranitidine.
Bezuidenhout DJ; Perold JG; Adams G
S Afr Med J; 1984 Jun; 65(25):1007-9. PubMed ID: 6328685
[TBL] [Abstract][Full Text] [Related]
7. Ulcer healing and relapse prevention by ranitidine in peptic ulcer disease.
Liedberg G; Davies HJ; Enskog L; Eriksson S; Frederiksen B; Graffner H; Hradsky M; Oscarson J; Rydberg B; Simert G
Scand J Gastroenterol; 1985 Oct; 20(8):941-4. PubMed ID: 3909374
[TBL] [Abstract][Full Text] [Related]
8. Antacid/anticholinergic, cimetidine, and placebo in treatment of active peptic ulcers.
Ström M; Gotthard R; Bodemar G; Walan A
Scand J Gastroenterol; 1981; 16(5):593-602. PubMed ID: 7034155
[TBL] [Abstract][Full Text] [Related]
9. Double blind comparative study of omeprazole and ranitidine in patients with duodenal or gastric ulcer: a multicentre trial. Cooperative study group.
Gut; 1990 Jun; 31(6):653-6. PubMed ID: 2199347
[TBL] [Abstract][Full Text] [Related]
10. Effect of H2-receptor blockade by ranitidine on ulcer healing and gastric acid secretion in patients with gastric and duodenal ulcers.
Forssell H; Koch G
Eur J Clin Pharmacol; 1983; 25(2):195-8. PubMed ID: 6313376
[TBL] [Abstract][Full Text] [Related]
11. Ranitidine versus anticholinergic/antacid for duodenal ulcer. A randomized, endoscopically controlled, single-blind multicentre trial.
Miettinen P; Anttonen V; Aukee S; Huttunen R; Lahtinen J; Poikolainen E; Pääkkönen M; Tammela T
Scand J Gastroenterol; 1985 Aug; 20(6):701-5. PubMed ID: 3898348
[TBL] [Abstract][Full Text] [Related]
12. Safety of ranitidine maintenance treatment of duodenal ulcer.
Boyd EJ; Wilson JA; Wormsley KG
Scand J Gastroenterol; 1984 May; 19(3):394-400. PubMed ID: 6330871
[TBL] [Abstract][Full Text] [Related]
13. Sucralfate and ranitidine in the treatment of acute duodenal ulcer. Healing and relapse. Ulcer Study Group.
Koelz HR; Halter F
Am J Med; 1989 Jun; 86(6A):98-103. PubMed ID: 2660563
[TBL] [Abstract][Full Text] [Related]
14. Ranitidine and antacids in the prevention of duodenal ulcer relapse in Greece.
Kalantzis N; Theodoropoulos G; Katsaros D; Tzivras M; Fertakis A; Archimandritis A
Hepatogastroenterology; 1992 Jun; 39(3):277-9. PubMed ID: 1505904
[TBL] [Abstract][Full Text] [Related]
15. Ranitidine, cimetidine and antacids in the prevention of recurrence after healed duodenal ulcer: one-year experience.
Bresci G; Capria A; Rindi G; Geloni M; Federici G; Corsini G
Int J Tissue React; 1983; 5(4):345-8. PubMed ID: 6323335
[TBL] [Abstract][Full Text] [Related]
16. Ranitidine in the prevention of gastric and duodenal ulcer relapse.
Alstead EM; Ryan FP; Holdsworth CD; Ashton MG; Moore M
Gut; 1983 May; 24(5):418-20. PubMed ID: 6301956
[TBL] [Abstract][Full Text] [Related]
17. Controlled clinical trial of duodenal ulcer healing with antacid tablets.
Berstad A; Rydning A; Aadland E; Kolstad B; Frislid K; Aaseth J
Scand J Gastroenterol; 1982 Oct; 17(7):953-9. PubMed ID: 6130599
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of ranitidine 150 mg at bedtime as maintenance therapy for healed gastric ulcers.
Sue SO; Dawson DM; Brown JA; Wood DR; Kleoudis CS
Clin Ther; 1996; 18(6):1175-83. PubMed ID: 9001834
[TBL] [Abstract][Full Text] [Related]
19. Ranitidine and cimetidine in prevention of duodenal ulcer relapse. A double-blind, randomised, multicentre, comparative trial.
Gough KR; Korman MG; Bardhan KD; Lee FI; Crowe JP; Reed PI; Smith RN
Lancet; 1984 Sep; 2(8404):659-62. PubMed ID: 6147693
[TBL] [Abstract][Full Text] [Related]
20. Ulcer recurrence following duodenal ulcer healing with omeprazole, ranitidine, or placebo: a double-blind, multicenter, 6-month study. The Omeprazole Duodenal Ulcer Study Group.
Graham DY; Colon-Pagan J; Morse RS; Johnson TL; Walsh JH; McCullough AJ; Marks JW; Sklar M; Stone RC; Cagliola AJ
Gastroenterology; 1992 Apr; 102(4 Pt 1):1289-94. PubMed ID: 1551535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
